TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells

• DOI: 10.1371/journal.pgen.1011159
• Publication Date: 2024-02-20T18:34:52Z
• Authors: Thomas G. Scott; Kizhakke Mattada ...; Daniel Gioeli; Michael J. Guertin
• Keywords: Langer-Giedion Syndrome; Estrogen Receptor alpha; Gene Expression; Breast Neoplasms; QH426-470; Nose; GATA Transcription Factors; Article; Chromatin; 3. Good health; Genes, cdc; Repressor Proteins; Fingers; Genetics; Humans; Female; Hair Diseases; Research Article

Common genetic variants in the repressive GATA-family transcription factor (TF) TRPS1 locus are associated with breast cancer risk, and luminal breast cancer cell lines are particularly sensitive to TRPS1 knockout. We introduced an inducible degron tag into the native TRPS1 locus within a luminal breast cancer cell line to identify the direct targets of TRPS1 and determine how TRPS1 mechanistically regulates gene expression. We acutely deplete over 80 percent of TRPS1 from chromatin within 30 minutes of inducing degradation. We find that TRPS1 regulates transcription of hundreds of genes, including those related to estrogen signaling. TRPS1 directly regulates chromatin structure, which causes estrogen receptor alpha (ER) to redistribute in the genome. ER redistribution leads to both repression and activation of dozens of ER target genes. Downstream from these primary effects, TRPS1 depletion represses cell cycle-related gene sets and reduces cell doubling rate. Finally, we show that high TRPS1 activity, calculated using a gene expression signature defined by primary TRPS1-regulated genes, is associated with worse breast cancer patient prognosis. Taken together, these data suggest a model in which TRPS1 modulates the genomic distribution of ER, both activating and repressing transcription of genes related to cancer cell fitness.